USANA Health Sciences (USNA) Tops Q2 EPS by 19c
Tweet
Share
E-mailGet Alerts USNA Hot Sheet
Price: $14.17 -4.13%
EPS Growth %: +386.7%
Financial Fact:
Net earnings: 30.1M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +386.7%
Financial Fact:
Net earnings: 30.1M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q2 EPS of $0.89, $0.19 better than the analyst estimate of $0.70. Revenue for the quarter came in at $238 million versus the consensus estimate of $231.14 million.
GUIDANCE:
USANA Health Sciences sees FY2023 EPS of $2.65-$3.30, versus the consensus of $3.02. USANA Health Sciences sees FY2023 revenue of $900-950 million, versus the consensus of $940.57 million.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- UBS Reiterates Buy Rating on KB Home (KBH) Amid Transition Back to Built-to-Order
- Aytu BioScience (AYTU) Tops Q4 EPS by 28c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
